Eleftherios Tsiamis

Eleftherios Tsiamis

Auto-generated profile, based on publicly available information

Eleftherios Tsiamis

First Department of Cardiology, Hippokration Hospital, Athens Medical School, National and Kapodistrian University of Athens, Vas. Sofias 114, 11527 Athens, Greece

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
CAConstantina Aggeli
Constantina Aggeli
YDYannis Dimitroglou
Yannis Dimitroglou
LRLeonidas Raftopoulos
Leonidas Raftopoulos
GSGeorgia Sarri
Georgia Sarri
Sophie I. MavrogeniSophie I. Mavrogeni
Sophie I. Mavrogeni
KTKonstantinos Tsioufis
Konstantinos Tsioufis
Cardiac masses are space occupying lesions within the cardiac cavities or adjacent to the pericardium. They include frequently diagnosed clinical entities such as clots and vegetations, common benign tumors such as myxomas and papillary fibroelastomas and uncommon benign or malignant primary or metastatic tumors. Given their diversity, there are no guidelines or consensus statements regarding the best diagnostic or therapeutic approach. In the past, diagnosis used to be made by the histological specimens after surgery or during the post-mortem examination. Nevertheless, evolution and increased availability of cardiovascular imaging modalities has enabled better characterization of the masses and the surrounding tissue. Transthoracic echocardiography using contrast agents can evaluate the location, the morphology and the perfusion of the mass as well as its hemodynamic effect. Transesophageal echocardiography has increased spatial and temporal resolution; hence it is superior in depicting small highly mobile masses. Cardiac magnetic resonance and cardiac computed tomography are complementary providing tissue characterization. The scope of this review is to present the role of cardiovascular imaging in the differential diagnosis of cardiac masses and to propose a step-wise diagnostic algorithm, taking into account the epidemiology and clinical presentation of the cardiac masses, as well as the availability and the incremental value of each imaging modality.

1 August 2012 in EuroIntervention
Verified
Journal Article
Closed access
KTKonstantinos Toutouzas
Konstantinos Toutouzas
AKAntonios Karanasos
Antonios Karanasos
MRMaria Riga
Maria Riga
ETEleftherios Tsiamis
Eleftherios Tsiamis
ASAndreas Synetos
Andreas Synetos
CSChristodoulos Stefanadis
Christodoulos Stefanadis
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Verified
Journal Article
Open access
PDF file
Anastasia BaltaAnastasia Balta
Anastasia Balta
Alexandr Ceasovschih, Assist. Prof., PhDAlexandr Ceasovschih, Assist. Prof., PhD
Alexandr Ceasovschih, Assist. Prof., PhD
VSVictorita Sorodoc
Victorita Sorodoc
Kyriakos DimitriadisKyriakos Dimitriadis
Kyriakos Dimitriadis
SGSara Guzel
Sara Guzel
LSLaurentiu Sorodoc
Laurentiu Sorodoc
Electrocardiogram (ECG) still remains a very useful diagnostic method in modern cardiology. Its broad availability, noninvasiveness and good sensitivity explain why it plays a capital role in the very beginning of the process of diagnosis for every patient, with or without cardiac-related complaints. For the practitioner, good training in ECG interpretation is mandatory. Sometimes, the ECG trace reveals particular aspects that may cause confusion and complicate decision-making. In this article, we present several less common situations underlying the general context and ECG features. The syndromes studied have a high pathological significance and may range from acute emergencies that call for a rapid therapeutical response to chronic syndromes that require prolonged observation, monitoring and risk stratification.

1 November 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
CAConstantina Aggeli
Constantina Aggeli
IFIoannis Felekos
Ioannis Felekos
SKStelios Kastellanos
Stelios Kastellanos
VPVassiliki Panagopoulou
Vassiliki Panagopoulou
EVANGELOS OIKONOMOUEVANGELOS OIKONOMOU
EVANGELOS OIKONOMOU
Dimitris TousoulisDimitris Tousoulis
Dimitris Tousoulis

17 July 2007
Verified
Journal Article
Closed access
KFKonstantinos Filis
Konstantinos Filis
FAFotios Arhontovasilis
Fotios Arhontovasilis
DTDimitrios Theodorou
Dimitrios Theodorou
KAKonstantinos Albanopoulos
Konstantinos Albanopoulos
ELEmmanuel Lagoudianakis
Emmanuel Lagoudianakis
CSChristodoulos Stefanadis
Christodoulos Stefanadis

20 June 2023 in Life
Verified
Journal Article
Open access
PDF file
Kyriakos DimitriadisKyriakos Dimitriadis
Kyriakos Dimitriadis
NPNikolaos Pyrpyris
Nikolaos Pyrpyris
Konstantinos AznaouridisKonstantinos Aznaouridis
Konstantinos Aznaouridis
PIPanagiotis Iliakis
Panagiotis Iliakis
AVAggeliki Valatsou
Aggeliki Valatsou
KTKonstantinos Tsioufis
Konstantinos Tsioufis
Tricuspid regurgitation (TR) is a common valvular pathology, estimated to affect 1.6 million people in the United States alone. Even though guidelines recommend either medical therapy or surgical treatment for TR, the misconception of TR as a benign disease along with the high mortality rates of surgical intervention led to undertreating this disease and commonly describing it as a “forgotten” valve. Recently, the development of transcatheter interventions for TR show promising potential for use in the clinical setting. There are currently few approved and numerous tested percutaneously delivered devices, which can be categorized, based on their mechanism of action, to either valve repair or valve replacement procedures. Both procedures were tested in clinical trials and show an echocardiographic reduction in TR sustained for at least 1 year after the procedure, as well as symptom relief and functional improvement of the patients. Device selection should be personalized, taking into consideration the anatomy of each valve and the available options at each heart center. Moreover, appropriate patient selection and timing of the procedure are also crucial for the success of the procedure. In this review, we analyze the clinical trials available for all devices currently approved or tested, aiming to provide a comprehensive summary of the most recent evidence in the field of transcatheter TR interventions.